-
Signature
-
/s/ Heather Rees
-
Issuer symbol
-
ATOS
-
Transactions as of
-
15 May 2025
-
Transactions value $
-
$0
-
Form type
-
4
-
Filing time
-
16 May 2025, 16:05:13 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Rees Heather |
Chief Financial Officer |
C/O ATOSSA THERAPEUTICS, INC.,, 10202 5TH AVENUE NE SUITE 200, SEATTLE |
/s/ Heather Rees |
16 May 2025 |
0001997454 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ATOS |
Stock Option (right to buy) |
Award |
$0 |
+544K |
|
$0.00 |
544K |
15 May 2025 |
Common Stock |
544K |
$0.99 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: